Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses

Cancer Research

Volumn 68, Issue 4, 2008, Pages 1228-1235

  Zeelenberg, Ingrid S ^a,c   Ostrowski, Matias ^a   Krumeich, Sophie ^a   Bobrie, Angélique ^a   Jancic, Carolina ^a   Boissonnas, Alexandre ^a   Delcayre, Alain ^b   Le Pecq, Jean Bernard ^b   Combadière, Béhazine ^a   Amigorena, Sebastian ^a   Théry, Clotilde ^a,d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b ExoThera LLC   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; DNA VACCINE; HYBRID PROTEIN; LACTADHERIN; NAKED DNA; OVALBUMIN; OVALBUMIN C1C2 FUSION PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER IMMUNIZATION; CELL SECRETION; CONTROLLED STUDY; DNA IMMUNIZATION; EXOSOME; FIBROSARCOMA; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOGENICITY; MEMBRANE VESICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CHICK EMBRYO; FIBROSARCOMA; MICE; MICE, INBRED C57BL; MILK PROTEINS; OVALBUMIN; SECRETORY VESICLES; VACCINES, DNA;

EID: 39449101177     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-3163     Document Type: Article

References (32)

1. Ochsenbein AF. Principles of tumor immunosurveillance and implications for immunotherapy. Cancer Gene Ther 2002;9:1043-55.
2. Pardoll D. Does the immune system see tumors as foreign or self? Annu Rev Immunol 2003;21:807-39.
3. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998;188:1359-68.
4. Basu S, Binder RJ, Ramalingam T, Srivastava PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001;14:303-13.
5. Harshyne LA, Watkins SC, Gambotto A, Barratt-Boyes SM. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 2001;166:3717-23.
6. + T cell cross-priming via transfer of proteasome substrates. Science 2004;304:1318-21.
7. Wolfers J, Lozier A, Raposo G, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 2001;7:297-303.
8. Udono H, Srivastava PK. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 1993;178:1391-6.
9. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002;195:1289-302.
10. Li M, Davey GM, Sutherland RM, et al. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol 2001;166:6099-103.
11. Stubbs JD, Lekutis C, Singer KL, et al. cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences. Proc Natl Acad Sci U S A 1990;87:8417-21.
12. Andersen MH, Graversen H, Fedosov SN, Petersen TE, Rasmussen JT. Functional analyses of two cellular binding domains of bovine lactadherin. Biochemistry 2000;39:6200-6.
13. Shi J, Heegaard CW, Rasmussen JT, Gilbert GE. Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature. Biochim Biophys Acta 2004;1667:82-90.
14. Oshima K, Aoki N, Kato T, Kitajima K, Matsuda T. Secretion of a peripheral membrane protein, MFG-E8, as a complex with membrane vesicles. Eur J Biochem 2002;269:1209-18.
15. Veron P, Segura E, Sugano G, Amigorena S, Thery C. Accumulation of MFG-E8/lactadherin on exosomes from immature dendritic cells. Blood Cells Mol Dis 2005;35:81-8.
16. Miyasaka K, Hanayama R, Tanaka M, Nagata S. Expression of milk fat globule epidermal growth factor 8 in immature dendritic cells for engulfment of apoptotic cells. Eur J Immunol 2004;34:1414-22.
17. Delcayre A, Estelles A, Sperinde J, et al. Exosome display technology: applications to the development of new diagnostics and therapeutics. Blood Cells Mol Dis 2005;35:158-68.
18. Silvestre JS, Thery C, Hamard G, et al. Lactadherin promotes VEGF-dependent neovascularization. Nat Med 2005;11:499-506.
19. Karttunen J, Sanderson S, Shastri N. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci U S A 1992;89:6020-4.
20. Thery C, Clayton A, Amigorena S, Raposo G. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Vol. 1. Part 3. In: Bonifacino JS, Dasso M, Lippincott-Schwartz J, Harford JB, Yamada KM, editors. Current protocols in cell biology. New York: John Wiley & Sons; 2006. p. 3.22.01-29.
21. Restifo NP, Esquivel F, Asher AL, et al. Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response. J Immunol 1991;147:1453-9.
22. Hanayama R, Tanaka M, Miwa K, et al. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002;417:182-7.
23. Shi J, Shi Y, Waehrens LN, et al. Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death. Cytometry A 2006;69:1193-201.
24. Thery C, Boussac M, Veron P, et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001;166:7309-18.
25. Shen L, Rock KL. Cellular protein is the source of cross-priming antigen in vivo. Proc Natl Acad Sci U S A 2004;101:3035-40.
26. Kueng HJ, Leb VM, Haiderer D, et al. General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. J Virol 2007;81:8666-76.
27. Bellier B, Dalba C, Clerc B, et al. DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Vaccine 2006;24:2643-55.
28. + T cells against the wild-type tumor: correlation with antigen presentation capability. J Exp Med 1992;175:1423-31.
29. Andreola G, Rivoltini L, Castelli C, et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 2002;195:1303-16.
30. Valenti R, Huber V, Filipazzi P, et al. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-β-mediated suppressive activity on T lymphocytes. Cancer Res 2006;66:9290-8.
31. Clayton A, Tabi Z. Exosomes and the MICA-NKG2D system in cancer. Blood Cells Mol Dis 2005;34:206-13.
32. Liu C, Yu S, Zinn K, et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 2006;176:1375-85.